Dana-Farber/Children’s Hospital Cancer Center to partner with Egypt Cancer Network and Children’s Cancer Hospital Egypt
Creating Egypt-based fellowship training program for physicians from Egypt, the Middle East and North Africa Region
BOSTON – Dana-Farber/Children’s Hospital Cancer Center is announcing a partnership with the Egypt Cancer Network and Children’s Cancer Hospital Egypt in an effort to improve childhood cancer survival rates and outcomes within Egypt, the Middle East and North Africa. The organizations are collaborating to create an Egypt-based fellowship training program in pediatric oncology for physicians in those regions.
“Since beginning a twinning program between the Dana-Farber/Children’s Hospital Cancer Center and the Children’s Cancer Hospital Egypt in 2006, we have seen significant improvement in the outcome of pediatric cancer patients in Egypt,” said Mark Kieran, MD, PhD, director of medical neuro-oncology at Dana-Farber/Children’s Hospital Cancer Center and member of the medical advisory board for the Children’s Cancer Hospital Egypt 57357’s pediatric oncology fellowship program. “However, there is still a shortage of expertise and resources needed to treat children with cancer in this region.”
“The fellowship is designed to improve the childhood cancer survival rates and outcomes within Egypt, the Middle East and North Africa,” said Kieran. “This collaboration will allow the exchange of information, knowledge and experience for both doctors from the region and from the United States, providing the opportunity for the improvement of treatment and care practices.”
The collaboration will provide a formal fellowship framework for pediatric oncology training and mentoring for Egyptian, African and Middle Eastern pediatricians in line with international standards and will create a pool of qualified pediatric oncologists who can ensure continued progress in improving outcomes for children with cancer in this region.
As part of the fellowship, between 2 and 6 pediatric physicians from the Children’s Cancer Hospital Egypt will travel to Boston to work with specialists at Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC). In addition, DF/CHCC physicians will rotate at the Children’s Cancer Hospital Egypt to train oncologists there in the latest treatments and care techniques.
About the Dana-Farber / Children’s Hospital Cancer Center
Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) combines the strengths of Dana-Farber Cancer Institute, a world-class cancer institute, and Boston Children’s Hospital, an internationally known pediatric hospital. For over 60 years, these two Harvard Medical School affiliates have provided comprehensive care for children and adolescents with cancer. Committed to conducting research to better understand and treat childhood cancers, DF/CHCC is the Pediatric Oncology Experimental Therapeutics Investigator Consortium’s (POETIC) only Phase I Clinical Trial site in New England, and is home to one of the world’s most sophisticated and accomplished Pediatric Stem Cell Transplantation centers. DF/CHCC also offers comprehensive transitional and long-term survivorship programs to childhood cancer survivors of all ages.